Abstract  Description  Claims  Drawing  Cited references 

US20130280738A   [0007] 
US10107810B   [0008]  [0062] 
WO20037135A   [0010]  [0098]  [0098]  [0098] 
US20060040293A1   [0010] 
US2019183969AA   [0041] 
EP3477300A   [0075] 

N. Engl. J. Med.   [0007] 
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy   [0008] 
Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy   [0009] 
Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients   [0009] 
Exostosin 1/Exostosin 2-Associated Membranous Nephropathy   [0010] 
Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease   [0010] 
The Immunoassay Handbook   [0035]  [0036]  [0052]  [0067] 
Introduction to bioinformatics   [0041] 
Clustal W and Clustal X version 2.0   [0041] 
PLOS   [0041] 
Molecular Cloning   [0045] 
Gene Cloning   [0045] 
Strategies for Protein Purification   [0045] 
Antibody Purification   [0045] 
Guide to Protein Purification   [0045] 
Mountants and Antifades   [0049] 
Comparison of antifading agents used in immunofluorescence   [0049] 
Microphotometry in Immunofluorescence   [0049] 
Detection of Polypeptides on Blots Using Secondary Antibodies   [0053] 
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy   [0057] 
General aspects of autoimmune diagnostics   [0061] 
Autoimmune diagnostics   [0061] 
The Concise Manual of Apharesis Therapy   [0075] 
J. Clin. Aph.   [0075]